查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1437514

Loratadine市場，按等級類型、劑型、最終用途、國家和地區 - 2024-2032年行業分析、市場規模、市場佔有率和預測

Loratadine Market, By Grade Type, By Dosage Form, By End-Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 260 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023年Loratadine市場規模為 1.555 億美元，2024年至2032年複合CAGR為 2.8%。

Loratadine市場-市場動態

幾種過敏症的流行推動市場需求

由於許多過敏性疾病（包括皮膚過敏、過敏性鼻炎、過敏性氣喘、過敏性結膜炎和過敏性鼻炎）的發病率不斷增加，因此對疾病管理中的有效治療方法的需求量很大。遺傳傾向、生活方式的改變和環境變數是造成高疾病負擔的原因。例如，美國過敏、氣喘和免疫學院報告指出，2021年，全球 18-44 歲年齡層的人中有超過 25.7%經歷過季節性過敏。此外，花粉熱影響超過 7.8%的 18 歲及以上美國人。因此，在不久的將來，預計高收入和中等收入國家不斷上升的疾病負擔和人口變化將推動市場需求。

Loratadine市場 - 主要見解

根據研究分析師的分析，預計全球市場在預測期內（2024-2032年）每年將以 2.8%左右的CAGR成長

根據牌號類型細分，USP 標準牌號類別主導市場

根據劑型細分，片劑細分市場在2023年佔據最大市場佔有率

根據最終用途細分，預計線上藥局領域在預測期內將以最高CAGR成長

依地區分類，北美是2023年的主要收入來源

Loratadine市場-區隔分析：

全球Loratadine市場根據等級類型、劑型、最終用途和地區進行細分。

市場依等級類型分為四類：EP標準級、USP標準級、醫藥標準級及其他。 USP 標準等級類別主導市場。 USP 標準等級非常注重遵守品質和安全規則，這又提高了消費者的偏好和採用率。

市場依劑型分為四大類：膠囊劑、錠劑、糖漿劑及其他。平板電腦細分市場在2023年佔據最大的市場佔有率，預計在預測期內將繼續保持相同的格局。這主要是因為大的、經授權的藥丸形式很容易獲得且易於服用。

根據最終用途，市場分為三類：零售藥房、醫院藥房和線上藥房。預計線上藥局領域在預測期內將以最高的CAGR成長。該細分市場的成長歸因於便利性、可近性以及對數位健康解決方案日益成長的偏好等因素。

Loratadine市場-地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。這些區域根據開展業務的國家進一步分類。預計北美將在預測期內引領市場，因為該地區過敏發生率高，醫療保健系統完善，並且是Loratadine生產和行銷領域的主要參與者。此外，活躍的管線和Loratadine預計日益增強的適應性將促進預測期內的區域成長。美國氣喘與過敏基金會2022年的研究指出，約 25 個主要城市屬於過敏反應高風險類別。

Loratadine市場-競爭格局：

市場上的主要參與者包括Cadila Pharmaceuticals、Perrigo Company plc、Bayer AG、Morepen Laboratories Ltd、Viatris Inc.、Pfizer Inc.、Sun Pharmaceutical Industries Limited、Lannett、Tokyo Chemical Industry Co., Ltd.、Claritin、Merck KGaA ，Cipla Inc. 。為了進入新市場，市場參與者不斷採取各種策略性舉措，包括創造新產品、融資和投資、併購以及其他策略夥伴關係。

最近的發展：

2022年1月，Institut d'Investigacio Biomedica de Bellvitge 贊助了一項名為「Loratadine對淋巴管平滑肌瘤病（LORALAM）的影響」的臨床試驗，以評估Loratadine在LAM 中的安全性和可能的​​優勢，LAM 是一種以進行性囊性肺破壞為特徵的罕見致命疾病。

目錄

第1章 Loratadine市場概述

  • 研究範圍
  • 市場預估年份

第2章 執行摘要

  • 市場摘要
    • 按等級類型分類的Loratadine市場摘要
    • 按劑型分類的Loratadine市場摘要
    • 按最終用途分類的Loratadine市場摘要
    • 依國家分類的Loratadine市場摘要
    • 依地區分類的Loratadine市場摘要
  • 競爭洞察

第3章 Loratadine主要市場趨勢

  • Loratadine市場促進因素
    • 市場促進因素的影響分析
  • Loratadine市場限制
    • 市場限制影響分析
  • Loratadine市場機會
  • Loratadine市場未來趨勢

第4章 Loratadine產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章 Loratadine市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第6章 Loratadine市場格局

  • 2023年Loratadine市佔率分析
  • 細分資料：按主要製造商
    • 既有參與者分析
    • 新興參與者分析

第7章 Loratadine市場 - 依等級類型

  • 概述
    • 按等級類型分類的細分市場佔有率分析
    • EP標準級
    • USP 標準等級
    • 醫藥標準級
    • 其他

第8章 Loratadine市場 - 按劑型

  • 概述
    • 按劑型分類的細分市場佔有率分析
    • 膠囊
    • 平板電腦
    • 糖漿
    • 其他

第9章 Loratadine市場 - 依最終用途

  • 概述
    • 依最終用途分類的細分市場佔有率分析
    • 零售藥房
    • 醫院藥房
    • 網路藥房

第10章 Loratadine市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美Loratadine主要製造商
    • 北美市場規模和預測（依國家）
    • 北美市場規模和預測（按等級類型）
    • 北美市場規模與預測（按劑型）
    • 北美市場規模和預測（依最終用途）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲Loratadine主要製造商
    • 歐洲市場規模和預測（依國家）
    • 歐洲市場規模和預測（按等級類型）
    • 歐洲市場規模與預測（按劑型）
    • 歐洲市場規模和預測（依最終用途）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區（APAC）
    • 概述
    • Loratadine亞太地區主要製造商
    • 亞太地區市場規模與預測（依國家）
    • 亞太地區市場規模與預測（依等級類型）
    • 亞太地區市場規模與預測（按劑型）
    • 亞太地區市場規模和預測（依最終用途）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲Loratadine主要製造商
    • 拉丁美洲市場規模與預測（依國家）
    • 拉丁美洲市場規模與預測（按等級類型）
    • 拉丁美洲市場規模與預測（按劑型）
    • 拉丁美洲市場規模和預測（依最終用途）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲Loratadine主要製造商
    • 中東和非洲市場規模及預測（依國家）
    • 中東和非洲市場規模及預測（依等級類型）
    • 中東和非洲市場規模及預測（按劑型）
    • 中東和非洲市場規模和預測（依最終用途）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA的其他地區

第11章 主要供應商分析 - Loratadine產業

  • 競爭儀表板
  • 公司簡介
    • Cadila Pharmaceuticals
    • Perrigo Company plc
    • Bayer AG
    • Morepen Laboratories Ltd
    • Viatris Inc.
    • Pfizer Inc.
    • Sun Pharmaceutical Industries Limited
    • Lannett
    • Tokyo Chemical Industry Co., Ltd.
    • Claritin
    • Merck KGaA
    • Cipla Inc

第12章 360 度分析師視角

第13章 附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2232

REPORT HIGHLIGHT

Loratadine Market size was valued at USD 155.5 Million in 2023, expanding at a CAGR of 2.8% from 2024 to 2032.

The short-term relief of hay fever symptoms, which are caused by allergies to dust, pollen, or other airborne particles, is achieved with the use of loratadine. Sneezing, runny nose, and itchy eyes, nose, or throat are some of these symptoms. Additionally, loratadine is utilized to relieve hive-related redness and itching. But loratadine doesn't stop allergic skin responses like hives. Loratadine belongs to the group of drugs known as antihistamines. It functions by preventing the body's natural production of histamine, which is a chemical that triggers allergic reactions.

Loratadine Market- Market Dynamics

Growing prevalence of several allergies to propel market demand

Effective treatments in disease management will be in high demand due to the increasing frequency of many allergic disorders, including skin allergies, allergic rhinitis, allergic asthma, allergic conjunctivitis, and allergic rhinitis. Genetic predispositions, changing lifestyles, and environmental variables are responsible for the high illness burden. For instance, the American Academy College of Allergy, Asthma & Immunology reports that in 2021, over 25.7% of people worldwide in the 18-44 age range experienced seasonal allergies. Also, hay fever affects more than 7.8% of Americans who are 18 years of age and older. In the near future, it is thus expected that the rising illness burden and demographic change in high- and middle-income nations would drive market demand.

Loratadine Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 2.8% over the forecast period (2024-2032)

Based on grade type segmentation, the USP Standard Grade category dominates the market

Based on the dosage form segmentation, tablets segment held the largest market share in 2023

Based on end-use segmentation, the online pharmacy segment is expected to grow at the highest CAGR during the forecast period

Based on region, North America was the leading revenue generator in 2023

Loratadine Market- Segmentation Analysis:

The Global Loratadine Market is segmented based on Grade Type, Dosage Form, End-Use, and Region.

The market is divided into four categories based on grade type: EP Standard Grade, USP Standard Grade, Medicine Standard Grade and Others. The USP Standard Grade category dominates the market. The USP standard grade places a strong focus on adhering to quality and safety rules, which in turn increases consumer preference and adoption rates.

The market is divided into four categories based on the dosage form: Capsules, Tablets, Syrup and Others. The tablets segment held the largest market share in 2023 and is expected to continue the same pattern during the forecast period. This is mostly because large, authorized pill forms are readily available and are simple to administer.

The market is divided into three categories based on end-use: Retail Pharmacy, Hospital Pharmacy and Online Pharmacy. The online pharmacy segment is expected to grow at the highest CAGR during the forecast period. The segment growth is attributed to factors such as convenience, accessibility, and a growing preference for digital health solutions.

Loratadine Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to lead the market during the forecast period because the area has a high incidence of allergies, a well-established healthcare system, and major participants in the loratadine production and marketing sectors. Moreover, it is projected that active pipelines and loratadine's increasing adaptability would promote regional growth over the projection period. The Asthma and Allergy Foundation of America's 2022 study states that about 25 major cities fall into the high-risk category for allergic reactions.

Loratadine Market- Competitive Landscape:

The key players operating in the market are Cadila Pharmaceuticals, Perrigo Company plc, Bayer AG, Morepen Laboratories Ltd, Viatris Inc., Pfizer Inc., Sun Pharmaceutical Industries Limited, Lannett, Tokyo Chemical Industry Co., Ltd., Claritin, Merck KGaA, Cipla Inc. To obtain access to new markets, market players are continuously pursuing a variety of strategic initiatives, including the creation of new products, funding and investments, mergers and acquisitions, and other strategic partnerships.

Recent Developments:

In January 2022, Institut d'Investigacio Biomedica de Bellvitge is sponsoring a clinical trial called "Effect of Loratadine in Lymphangioleiomyomatosis (LORALAM)" to evaluate the safety and possible advantages of loratadine in LAM, a rare and fatal disease marked by progressive cystic lung destruction.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LORATADINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Cadila Pharmaceuticals

Perrigo Company plc

Bayer AG

Morepen Laboratories Ltd

Viatris Inc.

Pfizer Inc.

Sun Pharmaceutical Industries Limited

Lannett

Tokyo Chemical Industry Co., Ltd.

Claritin

Merck KGaA

Cipla Inc

GLOBAL LORATADINE MARKET, BY GRADE TYPE- MARKET ANALYSIS, 2019 - 2032

  • EP Standard Grade
  • USP Standard Grade
  • Medicine Standard Grade
  • Others

GLOBAL LORATADINE MARKET, BY DOSAGE FORM- MARKET ANALYSIS, 2019 - 2032

  • Capsules
  • Tablets
  • Syrup
  • Others

GLOBAL LORATADINE MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy

GLOBAL LORATADINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Loratadine Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Loratadine Market Snippet by Grade Type
    • 2.1.2. Loratadine Market Snippet by Dosage Form
    • 2.1.3. Loratadine Market Snippet by End-Use
    • 2.1.4. Loratadine Market Snippet by Country
    • 2.1.5. Loratadine Market Snippet by Region
  • 2.2. Competitive Insights

3. Loratadine Key Market Trends

  • 3.1. Loratadine Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Loratadine Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Loratadine Market Opportunities
  • 3.4. Loratadine Market Future Trends

4. Loratadine Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Loratadine Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Loratadine Market Landscape

  • 6.1. Loratadine Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Loratadine Market - By Grade Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Grade Type, 2023 & 2032 (%)
    • 7.1.2. EP Standard Grade
    • 7.1.3. USP Standard Grade
    • 7.1.4. Medicine Standard Grade
    • 7.1.5. Others

8. Loratadine Market - By Dosage Form

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Dosage Form, 2023 & 2032 (%)
    • 8.1.2. Capsules
    • 8.1.3. Tablets
    • 8.1.4. Syrup
    • 8.1.5. Others

9. Loratadine Market - By End-Use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-Use, 2023 & 2032 (%)
    • 9.1.2. Retail Pharmacy
    • 9.1.3. Hospital Pharmacy
    • 9.1.4. Online Pharmacy

10. Loratadine Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Loratadine Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Loratadine Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Loratadine Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Loratadine Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Loratadine Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Grade Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Loratadine Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Cadila Pharmaceuticals
    • 11.2.2. Perrigo Company plc
    • 11.2.3. Bayer AG
    • 11.2.4. Morepen Laboratories Ltd
    • 11.2.5. Viatris Inc.
    • 11.2.6. Pfizer Inc.
    • 11.2.7. Sun Pharmaceutical Industries Limited
    • 11.2.8. Lannett
    • 11.2.9. Tokyo Chemical Industry Co., Ltd.
    • 11.2.10. Claritin
    • 11.2.11. Merck KGaA
    • 11.2.12. Cipla Inc

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Loratadine Market: Grade Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Grade Type
  • TABLE Global Loratadine Market, by Grade Type 2019-2032 (USD Million)
  • TABLE Loratadine Market: Dosage Form Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Dosage Form
  • TABLE Global Loratadine Market, by Dosage Form 2019-2032 (USD Million)
  • TABLE Loratadine Market: End-UseSnapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-Use
  • TABLE Global Loratadine Market, by End-Use2019-2032 (USD Million)
  • TABLE Loratadine Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Loratadine Market, by Region 2019-2032 (USD Million)
  • TABLE North America Loratadine Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Loratadine Market, by Grade Type, 2019-2032 (USD Million)
  • TABLE North America Loratadine Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE North America Loratadine Market, by End-Use, 2019-2032 (USD Million)
  • TABLE Europe Loratadine Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Loratadine Market, by Grade Type, 2019-2032 (USD Million)
  • TABLE Europe Loratadine Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE Europe Loratadine Market, by End-Use, 2019-2032 (USD Million)
  • TABLE Asia Pacific Loratadine Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Loratadine Market, by Grade Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Loratadine Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE Asia Pacific Loratadine Market, by End-Use, 2019-2032 (USD Million)
  • TABLE Latin America Loratadine Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Loratadine Market, by Grade Type, 2019-2032 (USD Million)
  • TABLE Latin America Loratadine Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE Latin America Loratadine Market, by End-Use, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Loratadine Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Loratadine Market, by Grade Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Loratadine Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Loratadine Market, by End-Use, 2019-2032 (USD Million)